Preventing postoperative recurrence of Crohn's disease

British Journal of Surgery

Volumn 84, Issue 11, 1997, Pages 1493-1502

  Borley, N R ^a   Mortensen, N J ^a   Jewell, D P ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE;

CROHN DISEASE; DRUG EFFICACY; HUMAN; PRIORITY JOURNAL; RECURRENCE RISK; RECURRENT DISEASE; REVIEW; RISK FACTOR; SMOKING;

AGE FACTORS; ANASTOMOSIS, SURGICAL; ANTI-INFLAMMATORY AGENTS; COLORECTAL SURGERY; CROHN DISEASE; DEFECATION; HUMANS; POSTOPERATIVE CARE; RECURRENCE; RISK FACTORS; SEX FACTORS; TIME FACTORS;

EID: 0030657427     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1002/bjs.1800841104     Document Type: Review

References (119)

1. Crohn BB, Ginzburg L, Oppenheimer GD. Regional iletitis: a pathologic and clinical entity. JAMA 1932; 99: 1323-9.
2. Morson BC. Pathology of Crohn's disease. Clinical Gastroenterology 1972; 1: 265-77.
3. Farmer RG, Hawk WA, Turnbull RB Jr. Clinical patterns in Crohn's disease; a statistical study of 615 cases. Gastroenterology 1975; 68: 627-35.
4. Lockhart-Mummery HE, Morson BC. Crohn's disease of the large intestine. Gut 1964; 5: 493-509.
5. Lennard-Jones JE, Stalder GA. Prognosis after resection of chronic regional ileitis. Gut 1967; 8: 332-6.
6. Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl 1989; 170: 2-6.
7. Lee ECG, Papaioannou N. Recurrences following surgery for Crohn's disease. Clinical Gastroenterology 1980; 9: 419-38.
8. Best WR, Becktel JM, Singleton JW, Kern F Jr. Development of a Crohn's disease activity index. National Co-operative Crohn's Disease Study. Gastroenterology 1976; 70: 439-44.
9. Rutgeerts P, Geboes K, Vantrappen G, Kerremans R, Coenegrachts JL, Coremans G. Natural history of recurrent Crohn's disease at the ileocolonic anastomosis after curative surgery. Gut 1984; 25: 665-72.
10. Rutgeerts P, Geboes K, Vantrappen G, Beyls J, Kerremans R, Hiele M. Predictability of the postoperative course of Crohn's disease. Gastroenterology 1990; 99: 956-63.
11. Brignola C, Cottone M, Pera A et al. Mesalamine in the prevention of endoscopic recurrence after intestinal resection for Crohn's disease. Italian Cooperative Study Group. Gastroenterology 1985; 108: 345-9.
12. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. Journal of the American Statistical Association 1968; 53: 457-81.
13. Peto R, Pike MC, Armitage P et al. Design and analysis of randomized clinical trials requiring prolonged observations of each patient. I. Introduction and design. Br J Cancer 1976; 34: 585-612.
14. Peto R, Pike MC, Armitage P et al. Design and analysis of randomized clinical trials requiring prolonged observations of each patient. II. Analysis and examples. Br J Cancer 1977; 35: 1-39.
15. Wettergren A, Christiansen J. Risk of recurrence and reoperation after resection for ileocolic Crohn's disease. Scand J Gastroenterol 1991; 26: 1319-22.
16. Heen LO, Nygaard K, Bergan A. Crohn's disease. Results of excisional surgery in 133 patients. Scand J Gastroenterol 1984; 19: 747-54.
17. Nordgren SR, Fasth SB, Öresland TO, Hultén LA. Long-term follow-up in Crohn's disease. Mortality, morbidity and functional status. Scand J Gastroenterol 1994; 29: 1122-8.
18. Lock MR, Farmer RG, Fazio VW, Jagelman DG, Lavery IC, Weakley FL. Recurrence and reoperation for Crohn's disease: the role of disease location in prognosis. N Engl J Med 1981; 304: 1586-8.
19. Whelan G, Farmer RG, Fazio VW, Goormastic M. Recurrence after surgery in Crohn's disease. Relationship to location of disease (clinical pattern) and surgical indication. Gastroenterology 1985; 88: 1826-33.
20. Hellberg R, Hultén L, Rosengren C, Åhrén C. The recurrence rate after primary excisional surgery for Crohn's disease. Acta Chirurgica Scandinavica 1980; 146: 435-43.
21. Sayfan J, Wilson DA, Allan A, Andrews H, Alexander-Williams J. Recurrence after stricturoplasty or resection for Crohn's disease. Br J Surg 1989; 76: 335-8.
22. Higgens CS, Allan RN. Crohn's disease of the distal ileum. Gut 1980; 21: 933-40.
23. Lindhagen T, Ekelund G, Leandoer L, Hildell J, Lindström C, Wenckert A. Recurrence rate after surgical treatment of Crohn's disease. Scand J Gastroenterol 1983; 18: 1037-44.
24. Pallone F, Boirivant M, Stazi MA, Costintino R, Prantera C, Torsoli A. Analysis of clinical course of postoperative recurrence in Crohn's disease of the distal ileum. Dig Dis Sci 1992; 37: 215-19.
25. Trnka YM, Glotzer DJ, Kasdon EJ, Goldman H, Steer ML, Goldman LD. The long-term outcome of restorative operation in Crohn's disease. Influence of location, prognostic factors and surgical guidelines. Ann Surg 1982; 196: 345-53.
26. Raab Y, Bergström R, Ejerblad S, Graf W, Påhlman L. Factors influencing recurrence in Crohn's disease. An analysis of a consecutive series of 353 patients treated with primary surgery. Dis Colon Rectum 1996; 39: 918-25.
27. Pareja V, Martinez-Mas E, Lopez-Andujar R et al. Prognostic factors of recurrence following surgery for ileal and ileocolic Crohn's disease. Br J Surg 1996; 83(Suppl. 2): 88 (Abstract).
28. Goodman MJ, Skinner JM, Truelove SC. Abnormalities in the apparently normal bowel mucosa in Crohn's disease. Lancet 1976; i: 275-8.
29. Dunne WT, Cooke WT, Allan RN. Enzymatic and morphometric evidence for Crohn's disease as a diffuse lesion of the gastrointestinal tract. Gut 1977; 18: 290-4.
30. Olaison G, Smedh K, Sjödahl R. Natural course of Crohn's disease after ileocolic resection: endoscopically visualised ileal ulcers preceding symptoms. Gut 1992; 33: 331-5.
31. Caprilli R, Corrao G, Taddei G, Tonelli F, Torchio P, Viscido A. Gruppo Italiano per lo Studio del Colon e del Retto (GISC). Prognostic factors for postoperative recurrence of Crohn's disease. Dis Colon Rectum 1996; 39: 335-41.
32. Williams JG, Wong WD, Rothenberg DA, Goldberg SM. Recurrence of Crohn's disease after resection. Br J Surg 1991; 78: 10-19.
33. De Dombal FT, Burton I, Goligher JC. Recurrence of Crohn's disease after primary excisional surgery. Gut 1971; 12: 519-27.
34. Hellers G. Crohn's disease in Stockholm County 1955-1974. A study of epidemiology, results of surgical treatment and long-term prognosis. Acta Chirurgica Scandinavica 1979; Suppl 490: 1-84.
35. Kyle J. Prognosis after ileal resection for Crohn's disease. Br J Surg 1971; 58: 735-7.
36. Greenstein AJ, Sachar DB, Pasternack BS, Janowitz HD. Reoperation and recurrence in Crohn's colitis and ileocolitis. Crude and cumulative rates. N Engl J Med 1975; 293: 685-90.
37. Souftley A, Myren J, Clamp SE, Bouchier IA, Watkinson G, de Dombal FT. Factors affecting recurrence after surgery for Crohn's disease. Scand J Gastroenterol Suppl 1988; 144: 31-4.
38. Stahlgren LH, Ferguson LK. The results of surgical treatment of chronic regional enteritis. JAMA 1961; 175: 986-9.
39. Davis JM. The prognosis of Crohn's disease of the small intestine. Postgrad Med J 1961; 37: 783-91.
40. Shivananda S, Hordijk ML, Pena AS, Mayberry JF. Crohn's disease: risk of recurrence and reoperation in a defined population. Gut 1989; 30: 990-5.
41. Ellis L, Calhoun P, Kaiser DL, Rudolf LE, Hanks JB. Postoperative recurrence in Crohn's disease. The effect of the initial length of bowel resection and operative procedure. Ann Surg 1984; 199: 340-7.
42. Atwell JD, Duthie HL, Goligher JC. The outcome of Crohn's disease. Br J Surg 1965; 52: 966-72.
43. Michelassi F, Balestracci T, Chappell R, Block GE. Primary and recurrent Crohn's disease. Experience with 1379 patients. Ann Surg 1991; 214: 230-8.
44. Speranza V, Simi M, Leardi S, Del Papa M. Recurrence of Crohn's disease after resection. Are there any risk factors? J Clin Gastroenterol 1986; 8: 640-6.
45. Sahmoud T, Hoctin-Boes G, Modigliani R et al. Group d'Etudes Therapeutiques des Affections Inflammatoires Digestives. Identifying patients with a high risk of relapse in quiescent Crohn's disease. Gut 1995; 37: 811-18.
46. Chardavoyne R, Flint GW, Pollack S, Wise L. Factors affecting recurrence following resection for Crohn's disease. Dis Colon Rectum 1986; 29: 495-502.
47. Tobin MV, Logan RFA, Langman MJS, McConnell RB, Gilmore IT. Cigarette smoking and inflammatory bowel disease. Gastroenterology 1987; 93: 316-21.
48. Cosnes J, Carbonnel F, Beaugerie L, Le Quintrec Y, Gendre J-P. Effects of cigarette smoking on the long-term course of Crohn's disease. Gastroenterology 1996; 110: 424-31.
49. Lindberg E, Tysk C, Andersson K, Järnerot G. Smoking and inflammatory bowel disease. A case control study. Gut 1988; 29: 352-7.
50. Persson P-G, Ahlhom A, Hellers G. Inflammatory bowel disease and tobacco smoke - a case control study. Gut 1990; 31: 1377-81.
51. Franceschi S, Panza E, La Vecchia C, Parazzini D, Decarli A, Bianchi Porro G. Nonspecific inflammatory bowel disease and smoking. Am J Epidemiol 1987; 125: 445-52.
52. Silverstein M, Lashner B, Hanauer SB, Evans AA, Kirsner JB. Cigarette smoking in Crohn's disease. Am J Gastroenterol 1989; 84: 31-3.
53. Cottone M, Rosselli M, Orlando A et al. Smoking habits and recurrence in Crohn's disease. Gastroenterology 1994; 106: 643-8.
54. Sutherland LR, Ramcharan S, Bryant H, Fick G. Effects of cigarette smoking on recurrence of Crohn's disease. Gastroenterology 1990; 98: 1123-8.
55. Wyatt J, Vogelsang H, Hübl W, Walderhöer T, Lochs H. Intestinal permeability and the prediction of relapse in Crohn's disease. Lancet 1993; 341: 1437-9.
56. Boirivant M, Pallone F, Ciaco A, Leoni M, Fais S, Torsoli A. Usefulness of fecal alpha 1-antitrypsin clearance and fecal concentration as early indicator of postoperative asymptomatic recurrence in Crohn's disease. Dig Dis Sci 1991; 36: 347-52.
57. 2 activity. Scand J Gastroenterol 1992; 27: 691-4.
58. Roediger WEW, Giles A, Kaczmar A, Ali S. Does exclusion of enteral lipid assist remission in Crohn's disease? J Clin Gastroenterol 1993; 17: 38-41.
59. Peters WR, Fry RD, Fleshman JW, Kodner IJ. Multiple blood transfusions reduce the recurrence rate of Crohn's disease. Dis Colon Rectum 1989; 32: 749-53.
60. Williams JG, Hughes LE. Effect of perioperative blood transfusion on the recurrence of Crohn's disease. Lancet 1989; ii: 131-3.
61. Alvarez Perez JA, Baldonedo Cernuda RF, Jorge Barreiro JI. Perioperative blood transfusion and recurrence in Crohn's disease. Br J Surg 1996; 83 (Suppl 2): 88 (Abstract).
62. Scott AD, Ritchie JK, Phillips RK. Blood transfusion and recurrent Crohn's disease. Br J Surg 1991; 78: 455-8.
63. Hollaar GL, Gooszen HG, Post S, Williams JG, Sutherland LR. Perioperative blood transfusion does not prevent recurrence in Crohn's disease. A pooled analysis. J Clin Gastroenterol 1995; 21: 134-8.
64. Mekhjian HS, Switz DM, Watts HD, Deren JJ, Katon RM, Beman FM. National Cooperative Crohn's disease Study; factors determining recurrence of Crohn's disease after surgery. Gastroenterology 1979; 77: 907-13.
65. Post S, Herfarth C, Böhm E et al. The impact of disease pattern, surgical management, and individual surgeons on the risk for relaparotomy for recurrent Crohn's disease. Ann Surg 1996; 223: 253-60.
66. Holzheimer RG, Molloy RG, Wittmann DH. Postoperative complications predict recurrence of Crohn's disease. Eur J Surg 1995; 161: 129-35.
67. McDonald PJ, Fazio VW, Farmer RG et al. Perforating and nonperforating Crohn's disease. An unpredictable guide to recurrence after surgery. Dis Colon Rectum 1989; 32: 117-20.
68. Nygaard K, Fausa O. Crohn's disease. Recurrence after surgical treatment. Scand J Gastroenterol 1977; 12: 577-84.
69. Greenstein AJ, Lachman P, Sachar DB et al. Perforating and non-perforating indications for repeated operations in Crohn's disease: evidence for two clinical forms. Gut 1988; 29: 588-92.
70. Sachar DB, Subramani K, Mauer K et al. Patterns of postoperative recurrence in fistulizing and stenotic Crohn's disease. A retrospective cohort study of 71 patients. J Clin Gastroenterol 1996; 22: 114-16.
71. Sugita A, Fukushima T, Yamazaki Y et al. Postoperative recurrence form of Crohn's disease: a comparison between perforating and non perforating types. Nippon Geka Gakkai Zasshi 1993; 94: 114-18.
72. McLeod RS, Wolff BG, Steinhart AH et al. Prophylactic mesalamine treatment decreases postoperative recurrence of Crohn's disease. Gastroenterology 1995; 109: 404-13.
73. Tytgat GNJ, Mulder CJ, Brummelkamp WH. Endoscopic lesions in Crohn's disease early after ileocaecal resection. Endoscopy 1988; 20: 260-2.
74. de Jong E, van Dullemen HM, Slors JFM, Dekkers P, van Deventer SJH, Tytgat GNJ. Correlation between early recurrence and reoperation after ileocolonic resection in Crohn's disease: a prospective study. J Am Coll Surg 1996; 182: 503-8.
75. Bergman L, Krause U. Crohn's disease. A long-term study of the clinical course in 186 patients. Scand J Gastroenterol 1977; 12: 937-44.
76. Anseline PF, Wlodarczyk J, Murugasu R. Presence of granulomas is associated with recurrence after surgery for Crohn's disease: experience of a surgical audit. Br J Surg 1997; 84: 78-82.
77. Hamilton SR, Reese J, Pennington L, Boitnott JK, Bayless TM, Cameron JL. The role of resection margin frozen section in the surgical management of Crohn's disease. Surg Gynecol Obstet 1985; 160: 57-62.
78. Wolfson DM, Sachar DB, Cohen A et al. Granulomas do not affect post-operative recurrence in Crohn's disease. Gastroenterology 1982; 83: 405-9.
79. Hamilton SR. Pathologic features of Crohn's disease associated with recrudescence after resection. Pathol Annu 1983; 18(Part 1): 191-203.
80. Heuman R, Boeryd B, Bolin T, Sjödahl R. The influence of disease at the margin of resection on the outcome of Crohn's disease. Br J Surg 1983; 70: 519-21.
81. Pennington L, Hamilton SR, Bayless TM, Cameron JL. Surgical management of Crohn's disease. Influence of disease at margin of resection. Ann Surg 1980; 192: 311-18.
82. Kotangi H, Kramer K, Fazio VW, Petras RE. Do microscopic abnormalities at resection margins correlate with increased anastomotic recurrence in Crohn's disease? Dis Colon Rectum 1991; 34: 909-16.
83. Cooper JC, Williams NS. The influence of microscopic disease at the margin of resection on recurrence rates in Crohn's disease. Ann R Coll Surg Engl 1986; 68: 23-6.
84. Adloff M, Arnaud J-P, Ollier J-C. Does the histologic appearance at the margin of resection affect the postoperative recurrence rate in Crohn's disease? Am Surg 1987; 53: 543-6.
85. Fazio VW, Tjandra JJ, Lavery IC, Church JM, Milsom JW, Oakley JR. Long-term follow-up strictureplasty in Crohn's disease. Dis Colon Rectum 1993; 36: 355-61.
86. Stebbing JF, Jewell DP, Kettlewell MG, Mortensen NJ. Long-term results of recurrence and reoperation after strictureplasty for obstructive Crohn's disease. Br J Surg 1985; 82: 1471-4.
87. Serra J, Cohen Z, McLeod RS. Natural history of strictureplasty in Crohn's disease: 9-year experience. Can J Surg 1995; 38: 481-5.
88. Cameron JL, Hamilton SR, Coleman J, Sitzmann JV, Bayless TM. Patterns of ileal recurrence in Crohn's disease. A prospective randomized study. Br J Surg 1992; 215: 546-51.
89. Scott NA, Sue-Ling HM, Hughes LE. Anastomotic configuration does not affect recurrence of Crohn's disease after ileocolonic resection. Int J Colorectal Dis 1995; 10: 67-9.
90. Alexander-Williams J. Small bowel Crohn's disease. In: Inflammatory Bowel Diseases. 2nd ed. Allan RN, Keighley MRB, Alexander-Williams J, Hawkins C, eds. Edinburgh: Churchill Livingstone 1990: 459-72.
91. Burman JH, Thompson H, Cooke WT, Williams JA. The effects of diversion of intestinal contents on the progress of Crohn's disease of the large bowel. Gut 1971; 12: 11-15.
92. Sachar DB, Wolfson DM, Greenstein AJ, Goldberg J, Styczynski R, Janowitz HD. Risk factors for postoperative recurrence of Crohn's disease. Gastroenterology 1983; 85: 917-21.
93. Rutgeerts P, Goboes K, Peeters M et al. Impact of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum. Lancet 1991; 338: 771-4.
94. Smedh K, Olaison G, Sjödahl R. Ileocolic nipple valve anastomosis for preventing recurrence of surgically treated Crohn's disease. Long-term follow-up of six patients. Dis Colon Rectum 1990; 33: 987-90.
95. Harper PH, Lee ECC, Kettlewell MGW, Bennett MK, Jewell DP. Effect of the faecal stream in the maintenance of Crohn's colitis. Gut 1983; 24: 279-84.
96. Winslet MC, Keighley MRB. Fecal challenge as a predictor of the effect of restoring intestinal continuity in defunctioned Crohn's colitis. Gut 1988; 29: A1475 (Abstract).
97. Rutgeerts P, Hiele M, Geboes K et al. Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection. Gastroenterology 1995; 108: 1617-21.
98. Brignola C, Campieri M, Farruggia P et al. The possible utility of steroids in the prevention of relapses of Crohn's disease in remission. A preliminary study. Clinical Gastroenterology 1988; 10: 631-4.
99. Malchow H, Ewe K, Brandes JW et al. European Cooperative Crohn's Disease Study (ECCDS): results of drug treatment. Gastroenterology 1984; 86: 249-66.
100. Summers RW, Switz DM, Sessions JT Jr et al. National Cooperative Crohn's Disease Study: results of drug treatment. Gastroenterology 1979; 77: 847-69.
101. Bouhnik Y, Lemann M, Mary JY et al. Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine. Lancet 1996; 347: 215-19.
102. Wenckert A, Kristensen M, Ecklund AE et al. The long-term prophylactic effect of salazosulphapyridine (Salazopyrin) in primary resected patients with Crohn's disease. A controlled double-blind trial. Scand J Gastroenterol 1978; 13: 161-7.
103. Das KM, Eastwood MA, McManus JPA, Sircus W. Adverse reactions during salicylazosulfapyridine therapy and the relation with drug metabolism and acetylator phenotype. N Engl J Med 1973; 289: 491-5.
104. Nakshabendi IM, Duncan A, Russell RI. Is Asacol as effective as sulphasalazine in maintaining remission of Crohn's disease and ulcerative colitis? Postgrad Med J 1992; 68: 189-91.
105. Florent C, Cortot A, Quandale P et al. Placebo-controlled trial of Claversal (C) in the prevention of early endoscopic relapse after 'curative' resection for Crohn's disease. Gastroenterology 1992; 102(Suppl): A623 (Abstract).
106. Fiasse R, Fontaine F, Vanheuverzwyn R. Prevention of Crohn's disease recurrences after intestinal resection with Eudragid-L-coated 5-aminosalicylic acid. Preliminary results of a one year double-blind placebo controlled study. Gastroenterology 1991; 100(Suppl): A208 (Abstract).
107. Brignola C, Iannone P, Pasquali S et al. Placebo-controlled trial of oral 5-ASA in relapse prevention of Crohn's disease. Dig Dis Sci 1992; 37: 29-32.
108. Arber N, Odes HS, Fireman Z et al. A controlled double blind multicenter study of the effectiveness of 5-aminosalicylic acid in patients with Crohn's disease in remission. J Clin Gastroenterol 1995; 20: 203-6.
109. Prantera C, Pallone F, Brunetti G, Cottone M, Miglioli M, Italian IBD Study Group. Oral 5-aminosalicylic acid (Asacol) in the maintenance treatment of Crohn's disease. Gastroenterology 1992; 103: 363-8.
110. Gendre J-P, Mary JY, Florent C et al., Groupe d'Etudes Therapeutiques des Affections Inflammatoires Digestives (GETAID). Oral mesalamine (Pentasa) as maintenance treatment in Crohn's disease. A multicenter placebo-controlled study. Gastroenterology 1993; 104: 435-9.
111. Modigliani R, Colombel JF, Dupas JL et al., Group d'Etudes Therapeutiques des Affections Inflammatoires Digestives. Mesalamine in Crohn's disease with steroid-induced remission: effect on steroid withdrawal and remission maintenance. Gastroenterology 1996; 110: 688-93.
112. Steinhart AH, Hemphill D, Greenberg GR, Sulfasalazine and mesalazine for the maintenance therapy of Crohn's disease: a meta-analysis. Am J Gastroenterol 1994; 89: 2116-24.
113. Messori A, Brignola C, Trallori G et al. Effectiveness of 5-aminosalicylic acid for maintaining remission in patients with Crohn's disease: a meta-analysis. Am J Gastroenterol 1994; 89: 692-8.
114. Schreiber S, Howaldt S, Raedler A. Oral 4-aminosalicylie acid versus 5-aminosalicylic acid slow release tablets. Double blind, controlled pilot study in the maintenance treatment of Crohn's ileocolitis. Gut 1994; 35: 1081-5.
115. Dahlberg E, Thalen A, Brattsand R et al. Correlation between chemical structure, receptor binding, and biological activity of some novel highly active, 16α, 17α-acetyl-substituted glucocorticoids. Mol Pharmacol 1984; 25: 70-8.
116. Brattsand R. Overview of newer glucocorticoid preparations for inflammatory bowel disease. Can J Gastroenterol 1990; 4: 407-14.
117. Edsbäcker S, Wollmer P, Nilsson Å, Nilsson M. Pharmacokinetics and gastrointestinal transit of budesonide controlled ileal release (CIR) capsules. Gastroenterology 1993; 104(Suppl): A695 (Abstract).
118. Greenberg GR, Feagan BG, Martin F et al., Canadian Inflammatory Bowel Disease Study Group. Oral budesonide as maintenance treatment for Crohn's disease: a placebo-controlled, dose-ranging study. Gastroenterology 1996; 110: 45-51.
119. Löfberg R, Rutgeerts P, Malchow H et al. Budesonide prolongs time to relapse in ileal and ileocaccal Crohn's disease. A placebo controlled one year study. Gut 1996; 39: 82-6.